Skip to main content

Table 1 Characteristics of the non-oligometastatic patient cohort before and after PSM

From: Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies

Variable

Pre-PSM Cohort

Post-PSM Cohort

<63 Gy

≥63Gy

P value

<63 Gy

≥63Gy

P value

Total

93

90

 

59

59

 

Gender

      

 Male

66

59

0.431

47

38

0.065

 Female

27

31

12

21

 

Age (years)

      

 <60 years

52

48

0.726

31

27

0.461

 ≥60 years

41

42

28

32

 

KPS Score

      

 ≤80

58

52

 

32

32

 

 >80

35

38

0.526

27

27

1.000

Pathological type

      

 Squamous carcinoma

35

24

0.048

24

20

0.651

 adenocarcinoma

47

61

30

35

 

 Other

11

5

 

5

4

 

T status

      

 T1-2

33

36

0.529

19

22

0.562

 T3-4

60

54

40

37

 

N status

      

 N0-1

11

14

0.463

5

12

0.066

 N2-3

82

76

54

47

 

Response to chemotherapy

      

 Yes

64

68

 

43

43

1.000

 No

29

22

0.309

16

16

 

No. of chemotherapy cycles

      

 <4

63

32

<0.001

30

30

1.000

 ≥4

30

58

 

29

29

 

GTV volume (cm3)

      

 <146

44

40

0.697

23

23

1.000

 ≥146

49

50

36

36

 

Metastasis status

      

 Single organ

37

41

0.430

23

27

0.456

 2 to 3 organs

56

49

36

32

Â